CYTOSORBENTS CORPORATION Operating Lease, Liability, Noncurrent
CYTOSORBENTS CORPORATION (CTSO) had Operating Lease, Liability, Noncurrent of $11.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $11.60M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $11.75M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $11.90M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $12.05M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $11.60M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $11.75M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $11.90M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $12.05M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $12.19M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $12.32M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $12.44M 10-K · filed 2026-03-30 | $12.44M 10-K · filed 2025-03-31 |
| 2024-09-30 | $12.57M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $12.68M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $12.79M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $12.90M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $12.89M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.98M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $13.06M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $13.14M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $13.01M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $13.09M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $13.17M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $13.25M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $13.39M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $13.01M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $461.06K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $581.64K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $699.49K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $814.69K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $527.32K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $642.68K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $755.44K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $865.66K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $970.18K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.07M 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |